Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.47 |
| ▸ | MAOA | P21397 | 9/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2559162 | 0.81 | MAPT (0.57) | MAOBMAOAPTPN1MAPTMEN1 | |
| SCHEMBL2559161 | 0.81 | MAPT (0.57) | MAOBMAOAPTPN1MAPTMEN1 | |
| SCHEMBL25744219 | 0.80 | MAOB (0.53) | MAOBMAOAPTPN1MAPTPTGS2 | |
| SCHEMBL9110245 | 0.77 | MAOB (0.50) | MAOBMAOAPTPN1MAPTMEN1 | |
| SCHEMBL12903098 | 0.77 | MAOB (0.50) | MAOBMAOAPTPN1MAPTPTGS2 | |
| SCHEMBL19275439 | 0.77 | MAOB (0.50) | MAOBMAOAPTPN1MAPTPTGS2 | |
| SCHEMBL5689431 | 0.76 | MAOB (0.75) | MAOBMAOAPTPN1MAPTALDH1A1 | |
| SCHEMBL8051158 | 0.72 | MAOB (0.53) | MAOBMAOAPTPN1MAPTPTGS2 | |
| SCHEMBL5149191 | 0.72 | MAOB (0.53) | MAOBMAOAPTPN1MAPTMEN1 | |
| SCHEMBL30842883 | 0.72 | PTPN1 (0.75) | MAOBMAOAPTPN1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157159-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157159-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR0B1, AHR, ARL1 | MAOB 2797/4885MAOA 2602/4885PTPN1 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.